Brevetti EPO No.3758708 2024.11.27
Brevetti EPO
(10) Registration Number and Date
2025000062 2025.02.13
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2025/000062 2019.03.01
(40) Publication Number and Date
SM /T/2025/000062 2025.02.13
(30) Priority Details
US 201862636944 P
2018.03.01
(71/73) Applicant
(72) Inventor
(IT) WIKSTRÖM, Håkan : c/o Astrazeneca R&D Gothernberg, 431 83 Mölndal, SE
(IT) LUDVIGSSON, Jufang Wu : c/o Astrazeneca R&D Gothernberg, 431 83 Mölndal, SE
(IT) ANDERSSON, Thomas : c/o Astrazeneca R&D Gothernberg, 431 83 Mölndal, SE
(74) Representative Name
(IT) BUSCA, Andrea : Strada Caiese, 30, 47891 Dogana RSM, SM
(54) Title
(IT) COMPOSIZIONI FARMACEUTICHE COMPRENDENTI (2S)-{(1S)-1-CIANO-2-[4-(3-METIL-2-OSSO-2,3-DIIDRO-1,3-BENZOSSAZOL-5-IL)FENIL]ETIL}-1,4-OSSAZEPAN-2-CARBOSSAMMIDE
(EN) PHARMACEUTICAL COMPOSITIONS COMPRISING (2S)-{(1S)-1-CYANO-2-[4-(3-METHYL-2-OXO-2,3-DIHYDRO-1,3-BENZOXAZOL-5-YL)PHENYL]ETHYL}-1,4-OXAZEPANE-2-CARBOXAMIDE
(57) Abstract
(58) Citations